Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

No reported Stock-Based Compensation figures are available to summarize.

Stock-Based Compensation history

Currency unavailable · from the cash flow

No Stock-Based Compensation data reported for this period type.

Stock-Based Compensation vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Stock-Based Compensation for ODTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYRESpyre Therapeutics, Inc.LTM Sep 2026$50.3M USD+35.9%+74.2%55.6%
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$49.82M USD+13.3%+23.8%17.7%
ANABAnaptysBio, Inc.LTM Mar 2026$41.12M USD+24.3%+9.7%17.7%
ALMSAlumis Inc. Common StockLTM Jun 2026$36.4M USD-7.4%+94.0%492.0%
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$12.05M USD-2.1%-6.3%144.0%
IMUXImmunic, Inc.LTM Mar 2026$11.29M USD+44.4%+3.8%—
ORKAOruka Therapeutics, Inc.LTM Sep 2026$9.13M USD-54.6%——
ODTXOdyssey Therapeutics, Inc.—— ———
AGMBAgomAb Therapeutics N.V. American Depositary Shares—— ———
Peer median (excluding ODTX) —+13.3%+16.8%55.6%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.